Learn more on this topic: An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC

What are the genetic variants in NSCLC, and how are they used to select treatment?

Frank E. Mott

Related Material

Melinda Oliver: How do you identify and manage adverse events?

Melinda Oliver: How do you interpret a patient’s therapeutic response to treatment?

Frank E. Mott: What is the current thinking on diagnosis and treatment of patients with squamous cell NSCLC?

Whitney Lewis: What are the mechanisms of action of targeted treatments and immunotherapies?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.